BNY Mellon Outpaces State Street with Elite Margin Power
BNY Mellon posted stronger margins and revenue growth than State Street in Q1 2026, signaling a platform-led edge as ...
Learn which Dividend Aristocrats ETF charges the lowest fees and how that can impact long-term performance. We compare expense ratios and help you choose smarter.
27,457 articlesBNY Mellon posted stronger margins and revenue growth than State Street in Q1 2026, signaling a platform-led edge as ...
Monthly dividend stocks can help you smooth income and weather market swings. This deep dive explains how to spot the...
New data shows ULTY's steep cost, via a 1.24% expense ratio, quietly chewing into returns even as distributions persi...
In 2026, two healthcare real estate REITs stand out for income-focused investors: Community Healthcare Trust and Sabr...
A fresh look at SCHD shows that funding a cash-flow retirement with quarterly dividends still requires several millio...
When the AI rally paused, investors turned to dependable dividend names. Johnson Johnson, Altria, and Verizon led gai...
Pfizer’s stock has faced waves of headwinds, but a patient, long-term view can reveal an opportunity. This guide expl...
The dramatic shift policy just signaled by the Fed has set the stage for a new era in healthcare investing. Bristol M...
ADP extends its 51-year dividend growth streak, backed by a multi-billion-dollar cash wave. This report explains why ...
Ford’s 5% yield draws income investors, but the path to EV profitability and a big impairment bill raise questions ab...
Retirees are increasingly turning to the iShares MSCI Pacific ex-Japan ETF to secure dividend cash from Australia, Ho...
CareTrust's Q1 2026 earnings reveal steady cash flow and rising occupancy. This article breaks down what the numbers ...